7 November 2018

Yonne Peters and Peter Siersema obtained a MLDS grant of €250k for their project ‘Early detection of Barrett’s esophagus and esophageal cancer: accuracy and acceptability of a novel screening strategy in primary care’.

By 2030, 1 in 100 men in the Netherlands are predicted to be diagnosed with esophageal cancer during their lifetime. This large increase in incidence and the dismal prognosis of this tumor have stimulated interest the early detection of its precursor Barrett’s esophagus.The aim of the project is to determine the accuracy and acceptability of a non-invasive screening strategy (breath analysis with an electronic nose) followed by unsedated transnasal endoscopy (TNE)) for detecting Barrett’s esophagus and esophageal cancer in a primary care setting.Their ultimate goal is to implement breath test technology as a screening test in standard primary care for patients with (long-term) reflux symptoms. This may lead to an earlier detection of esophageal cancer, less invasive treatment, better survival rates, and even to the prevention of esophageal cancer.

This research was conducted within the theme: Tumors of the digestive tract

Related news items

Tailored drug dosage for pregnant women

14 March 2022 Three quarters of women in the Netherlands use some form of medication during pregnancy, but little is known about the appropriate dosages. Research by the Radboudumc, MUMC+ and Lareb Mothers of Tomorrow should change this. read more

Chella van der Post and Francesco Ciompi received a grant from Hanarth Foundation

11 November 2021 Unmasking the invisible cancer: digital detection of diffuse-type gastric carcinomas. read more

Q fever antibody does not predict disease progression

6 July 2021 Joint study by Radboudumc, Jeroen Bosch Hospital and UMC Utrecht. read more

First Dutch professor of infectious disease outbreaks at Radboud university medical center

4 June 2021 Chantal Bleeker-Rovers about research on coronavirus, Q fever and other infectious diseases outbreaks read more

First volunteers vaccinated with Radboudumc malaria vaccine

20 May 2021 Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc. read more

COVID-19 associated coagulopathy - lessons after 1 year

17 May 2021 Jenneke Leentjens, Saskia Middeldorp, and colleagues, published a review on the current knowledge of COVID-19 associated coagulopathy and the role of antithrombotic therapies in the Lancet Haematology. read more